These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6628930)

  • 1. Quantitative fecal indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease.
    Saverymuttu SH; Peters AM; Lavender JP; Pepys MB; Hodgson HJ; Chadwick VS
    Gastroenterology; 1983 Dec; 85(6):1333-9. PubMed ID: 6628930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between levels of C-reactive protein and clinical activity in Crohn's disease.
    Karoui S; Ouerdiane S; Serghini M; Jomni T; Kallel L; Fekih M; Boubaker J; Filali A
    Dig Liver Dis; 2007 Nov; 39(11):1006-10. PubMed ID: 17889628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
    Trebble TM; Wootton SA; Stroud MA; Mullee MA; Calder PC; Fine DR; Moniz C; Arden NK
    Aliment Pharmacol Ther; 2004 May; 19(10):1063-71. PubMed ID: 15142195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha 1-antitrypsin and the percentage of fecal excretion of 111In-oxin-labeled leukocytes in Crohn disease].
    Fischbach W; Becker W
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1233. PubMed ID: 3874762
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
    Jones J; Loftus EV; Panaccione R; Chen LS; Peterson S; McConnell J; Baudhuin L; Hanson K; Feagan BG; Harmsen SW; Zinsmeister AR; Helou E; Sandborn WJ
    Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1218-24. PubMed ID: 18799360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
    Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
    Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of activity parameters in Crohn's disease estimated by the faecal excretion of 111In-labeled granulocytes.
    Fischbach W; Becker W
    Digestion; 1991; 50(3-4):149-52. PubMed ID: 1812041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of disease activity in ulcerative colitis using indium-111-labelled leukocyte faecal excretion.
    Saverymuttu SH; Peters AM; Hodgson HJ; Chadwick VS
    Scand J Gastroenterol; 1983 Oct; 18(7):907-12. PubMed ID: 6676924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical remission in Crohn's disease--assessment using faecal 111In granulocyte excretion.
    Saverymuttu SH
    Digestion; 1986; 33(2):74-9. PubMed ID: 3949092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion.
    Saverymuttu SH; Camilleri M; Rees H; Lavender JP; Hodgson HJ; Chadwick VS
    Gastroenterology; 1986 May; 90(5 Pt 1):1121-8. PubMed ID: 3956932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indium-111-labeled autologous leukocyte imaging and fecal excretion. Comparison with conventional methods of assessment of inflammatory bowel disease.
    Leddin DJ; Paterson WG; DaCosta LR; Dinda PK; Depew WT; Markotich J; McKaigney JP; Groll A; Beck IT
    Dig Dis Sci; 1987 Apr; 32(4):377-87. PubMed ID: 3829880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's disease activity: assessment by factor VIII coagulation proteins.
    Zielen S; Bender SW; Kreuz W; Posselt HG; Solem E; Scharrer I
    J Pediatr Gastroenterol Nutr; 1985 Oct; 4(5):730-4. PubMed ID: 3930684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 111In-oxine-labelled white blood cells in the diagnosis and follow-up of Crohn's disease.
    Becker W; Fischbach W; Jenett M; Reiners C; Börner W
    Klin Wochenschr; 1986 Feb; 64(3):141-8. PubMed ID: 3081750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease.
    Folwaczny C; Wiebecke B; Loeschke K
    Am J Gastroenterol; 1999 Jun; 94(6):1551-5. PubMed ID: 10364024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral butyrate for mildly to moderately active Crohn's disease.
    Di Sabatino A; Morera R; Ciccocioppo R; Cazzola P; Gotti S; Tinozzi FP; Tinozzi S; Corazza GR
    Aliment Pharmacol Ther; 2005 Nov; 22(9):789-94. PubMed ID: 16225487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual fecal alpha 1-antitrypsin excretion reflects clinical activity in Crohn's disease but not in ulcerative colitis.
    Becker K; Berger M; Niederau C; Frieling T
    Hepatogastroenterology; 1999; 46(28):2309-14. PubMed ID: 10521988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.